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A novel polymorph of 10,11-dihydrocarbamazepine (form IV),
which had been predicted to be thermodynamically feasible, was
obtained from the vapour phase and displays an R22(8) hydrogen
bonded dimer motif in contrast to the catemeric motifs in forms
I–III.
10,11-Dihydrocarbamazepine (DHC) is a recognised impurity in
carbamazepine (CBZ), a dibenzazepine drug used in the treatment of
epilepsy.1 Here, DHC is of particular interest as part of a wider
investigation that combines experimental searches with crystal
structure prediction (CSP) to explore the basic science underpinning
structural diversity in CBZ and the closely related analogues, DHC,
cyheptamide (CYH) and cytenamide (CYT) (Fig. 1). In this
communication, we present the single-crystal structure of a new
dimer-based polymorph of DHC, form IV,† that was successfully
predicted by CSP methods. We also report on the structural rela-
tionships between DHC polymorphs as indicated by the XPac
program.2
DHC forms I (monoclinic),3 II (orthorhombic)4 and III (triclinic)5
all display the catemeric C(4) hydrogen-bonded motif shown in
Fig. 2, as does a 1:1 CBZ:DHC6 solid solution. Notably, the domi-
nance of the catemer motif in non-solvated DHC structures is in
marked contrast to the known polymorphs of CBZ7 and CYT8 that
contain only the dimer motif. CSP studies on DHC (this work) as
well as CBZ,9 CYH and CYT† have identified thermodynamically
competitive populations of hypothetical crystal structures that are
based on either the catemer motif or an R22(8)
10 dimer. However, prior
to this report only CYH had been crystallised in both dimer and
catemer motifs.11
The CSP results for DHC were challenged by employing a diverse
range of experimental crystallisation conditions in a search for pre-
dicted polymorphs and, in particular, potential dimeric structures.
The crystallisation methods used included an automated parallel
solution crystallisation study12,13 supplemented by manual solution
crystallisations, solvate desolvation plus recrystallisation from both
the melt and vapour phase. In total, 170 automated and manual
solution recrystallisations were implemented using a library of
71 solvents under 4 different conditions (details in the ESI).† These
produced DHC I, II and III in addition to six crystalline solvates
(formic acid,14 formamide,15 acetic acid,16 butyric acid, triflouroacetic
acid and DMSO17). A dimeric DHC motif is observed in the crys-
talline DMSO solvate, but in the other four known solvate structures
(see ESI)† DHC molecules form an R22(8) motif with the carboxylic
acid or amide group of the solvent molecule in preference to
a solvated DHC dimer or catemer. Desolvation of polycrystalline
samples of these solvates, including DHC:DMSO, produced DHC I
and/or II (see ESI). Crystallisation of DHC from the melt failed due
to rapid and complete decomposition upon melting to produce
10,11-dihydro-5H-dibenzo[b,f]azepine.18
Single-crystals of form IV were obtained, together with those of
form I and II, by crystallisation from the vapour phase via sub-
limation.‡ Single-crystal analysis was carried out on a small needle
shaped crystal at 123(2) K. The single-crystal structure is shown in
Fig. 3 overlaid with the matching predicted structure (ak2, Table S4
in ESI†) found in the CSP search 10 kJ mol1 above the global
minimum.
Fig. 1 CBZ and related structural analogues DHC, CYH and CYT.
Fig. 2 The C(4) catemer motif observed in DHC forms I–III (form I
shown) and also in CYH form I and in a 1:1 solid solution of DHC:CBZ
(N–H/O and N–H/p contacts shown as dashed lines).
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DHC can adopt one of two molecular conformations depending
on the orientation of the carboxamide group relative to the C10–C11
bond (Fig. 4). The lower energy anti-conformer is observed in DHC I,
II and III and the known solvate structures except that of the
disordered DHC:DMSO, in which both the anti- and syn-conformers
are both present with fractional occupancies of 0.81 and 0.19
respectively. DHC form IV however contains the syn-conformer that
is estimated to be <2 kJ mol1 less stable than the anti,x a value
consistent with the values expected for conformational poly-
morphism. Using the approximate crystal energy landscape (as in ref.
9, details in the ESI),† generated assuming the molecule adopted one
of these gas-phase optimised conformations, DHC II was found to be
the most stable structure. It also showed catemer-based structures
generated from the syn conformation that were almost as stable as
forms I and III (e.g. fc13 in the ESI).† Dimer-based structures were
significantly less stable (by about 5 kJ mol1) with DHC form IV
further destabilised by the conformational energy penalty associated
with the syn-conformer. A previously published CSP study on DHC20
also predicted form II as the global minimum, and found the lowest
energy syn-conformer (catemeric) structure and lowest energy dimeric
structure to be ca. 7 and 6 kJ mol1 above the global minimum,
respectively. At the time, these authors estimated that structures
greater than 5 kJ mol1 above the global minimum were unlikely to
be observed.20
The packing arrangement of DHC molecules in form IV was
compared to the other three polymorphs using the XPac method and
the same procedures applied previously to 25 CBZ related struc-
tures,21 CYH I and II11 and CYT I and II.8 Three supramolecular
constructs2 (SCs) are observed more than once across the four DHC
polymorph structures and their structural relationships are illustrated
in Fig. 4. The 1D SCs A and A1 are observed in DHC I, III and IV,
whilst the catemer, B, is observed in I, II and III. Fig. 4 also
highlights two motifs that occur only once across the four DHC
structures considered in the analysis, namely the 0D hydrogen-
bonded dimer in IV (C) and an offset 1D stack of DHC molecules
(D) in form II. The combination of SCs A1 and B in DHC I
(monoclinic) and III (triclinic) results in structures with a high degree
of 3D correspondence.
A previous XPac analysis of forms I and II of the related molecule
CYH,11 identified that the 1D stack equivalent to A in Fig 4. is
preserved in both structures, despite the change in hydrogen bonding
(catemer/ dimer) that accompanies the CYH I/ II thermal phase
transition. Similarly for DHC, the importance of space-filling effects
is evident, with non-hydrogen bonded 1D stacks of DHC molecules
(SC A1) observed in forms I, III and IV. The catemer and dimer
hydrogen bonding motifs in these structures therefore arise from
altered packing of the common molecular stack, A1, as highlighted in
the packing diagrams in Fig. 4.
In general terms, the discovery of this new dimer-based polymorph
of DHC provides another example of the successful application of
CSP technologies to identify favourable packing motifs and crystal
structures. An important caveat in the context of informing experi-
mental polymorph discovery however, is the need to consider the
predicted structures within a reasonably large energy range as being
possible, given the likely error in calculating relative crystal energies.
It has recently been shown that the relative energies of predicted CBZ
structures are sensitive to the modelling of molecular flexibility22,23
and intermolecular forces, although the explicit modelling of the
distortion of the charge distribution within the crystal24 may be less
important for DHC.20 Whilst reliable calculations of the relative
ambient free energies of organic crystals are a major challenge to
computational chemistry, the discovery of DHC IV confirms that
the approximate lattice energy landscape provides a meaningful
Fig. 4 Tree diagram illustrating the similarity relationships between
DHC I, II, III and IV. From top to bottom: DHC and the syn- and anti-
conformers; SC A, a 1D stack; 1D SC A1 composed of two inversion
related A stacks (A1 comprises anti-conformers in I and III and
syn-conformers in IV); SC B, a 1D catemeric arrangement. A, A1 and B
are each viewed perpendicular to the SC translation vector. Motifs C,
a 0D dimer, and D, an offset 1D stack are observed only in forms IV and
II, respectively. The packing diagrams for I, III and IV are viewed parallel
to the A1 translation vector and the blue ovals highlight the different
relative orientations of the A1 stacks in the catemeric (I, III) and dimeric
(IV) structures. The diagrams at the base of the figure illustrate which of
the two principle 1D stacking arrangements are observed in the structures
(i.e. A1 in I, III and IV and D in II).
Fig. 3 Crystal structure of DHC IV viewed down the b-axis showing the
centrosymmetric R22(8) dimers (N–H/O contacts shown as dashed lines).
The predicted structure ak2 is overlaid (red sticks). A comparison of form
IV and ak2 using the packing similarity tool in Mercury 2.219 yields an
RMS value of 0.33 A˚ for a 15 molecule coordination group.

















































indication of potential solid-state diversity, establishing a rationale for
experimental investigation of the true crystal energy landscape. In the
case of DHC, there are other predicted structures that may reason-
ably be expected to crystallise in preference to the syn-dimer based
DHC IV, such as ak61 (see ESI) that shows identical packing of the
more stable anti-conformer. Clearly, nucleation is important in
determining which energetically feasible structures are actually
observed as polymorphs, however, the concomitant formation of
DHC I, II and IV from the vapour phase illustrates the considerable
challenge of predicting the impact of kinetic factors involved in
crystallisation.
In conclusion, DHC IV represents an important advance in
defining the true extent of solid-state structural diversity of the
molecules in Fig. 1, as summarised in Table 1. With two of the four
compounds (DHC and CYH) having now been shown to adopt both
dimer and catemer based crystal structures in accordance with CSP,
the continued challenge to experimental and computational tech-
nologies is to provide confirmation of whether CBZ and CYT can or
cannot form polymorphs based on the catemer motif.
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‡ 20 mg of DHC, obtained from Aldrich, was placed in a 10 mL glass
volumetric flask in which a glass fibre was suspended. A small crystal of
CYT I was attached to the fibre. The container was sealed and placed on
a hot plate at 100 C and left for 24 h after which fine crystals were
observed on the glass fibre. Individual crystals were identified using
single-crystal diffraction, confirming the presence of forms I, II and IV in
the recrystallised sample. Although there is no evidence to suggest DHC
IV grew on the surface of the CYT I crystal, further studies are ongoing to
assess the reproducibility of DHC IV in the absence of heterochemical
seeds and to obtain bulk samples of form IV for characterisation of the
physical properties. DHC IV. C15H14N2O, Mr ¼ 238.28, Bruker-AXS
Kappa Apex II instrument, Mo radiation (l ¼ 0.71073 A˚), Experimental
structure [values for predicted ak2]: monoclinic, P21/c, a ¼ 13.207(6)
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parameters, R ¼ 0.043 [based on F and 1566 data with F2 > 2s (F2),
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x The syn-conformer is estimated to be less stable than the anti by
1.7 kJ mol1 at the MP2 level (ESI) and 1.43 at the SCF level with
a 6–31G(d,p) basis set, and 1.67 kJ mol1 (DFT calculations with PW91
functional and DNP basis set) ref 20, by full optimisation of the two
conformers.
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Table 1 Dimer and catemer hydrogen bonding motifs in the crystal
structures of CBZ, DHC, CYT and CYH
Polymorphs R22(8) C(4)
CBZ 4 4 —
DHC 4 1 3
CYH 2 1 1
CYT 2 2 —
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